Infection Surveillance Solutions Market Insights

The Infection Surveillance Solutions Market had a value of USD 423.4 million in 2022, with a Compound Annual Growth Rate (CAGR) of 12.2% during the forecast period of 2023-2030. The market is anticipated to reach a worth of USD 1,034.43 million by 2030. The market growth is fueled by the growing demand for infection control and prevention in healthcare settings, as well as the increasing incidence of hospital-acquired infections.

Application

Infection surveillance solutions are designed to monitor, track, and analyze information related to infections that occur in healthcare facilities such as hospitals, clinics, and long-term care facilities. These solutions aim to detect and monitor outbreaks, monitor compliance with infection control protocols, and implement specific measures to prevent the spread of infections.

Region

The infection surveillance solutions market is divided into regions, namely North America, Europe, Asia-Pacific, and the Rest of the World, with North America being the most significant region. The US holds the majority of the market share, making North America the largest market for infection surveillance solutions. The presence of well-developed healthcare infrastructure and a high occurrence of hospital-acquired infections are the driving forces behind this region.

Get Sample Report Here: https://marketresearchcommunity.com/sample-request/?rid=1982

Segment

The infection surveillance solutions market is segmented by product type, deployment mode, end user, and region. Based on product type, the market is segmented into software, services, and hardware. By deployment mode, the market is segmented into cloud-based and on-premise solutions. The end-user segment includes hospitals, long-term care facilities, and others.

Market Segmentation

By Component:

Software (On-Premise Software And Web Based Software) and Services (Training & Consulting Services, Implementation Services, and Others)

By Infection Type:

Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Central Line-Associated Bloodstream Infections (CLABSI), Catheter-Associated Urinary Tract Infection (CAUTI), and Others

By End-use:

Hospitals, Clinics, Long Term Care Facilities, Academic Institutes and Others.

By Region:

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Market value

The growth of the market is driven by the increasing prevalence of hospital-acquired infections, the rising demand for infection control and prevention measures, and the technological advancements in healthcare IT.

In conclusion, the infection surveillance solutions market is a rapidly growing sector of the healthcare industry, with a projected value of $1.8 billion by 2027. The market is being driven by the increasing need for infection control and prevention in healthcare facilities, as well as the rising prevalence of hospital-acquired infections. The market is segmented by application, region, segment, and market value, and is expected to continue its growth trajectory in the coming years.

The study provides answers to the following key questions:

• What type of customers buying the products and services from companies operating in the Infection Surveillance Solutions Market?

• What will be the roadmap for the product manufacturers operating in the Infection Surveillance Solutions Market for the forecast period, 2023-2030?

• What are the recent developments in the competitive landscape to look out for during the estimated period?

• What are the major trends influencing customers’ lives and their buying behaviour?

• How can brands best communicate with the customers they intend to target?

• When, where and how the customers want to use or consume the products or services?

Contact Us:

Market Research Community

Email:sales@marketresearchcommunity.com

Infection Surveillance Solutions Market Challenges, Forecast 2030